首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis
【24h】

Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis

机译:正电子发射断层扫描评估主动脉瓣狭窄患者的瓣膜钙化和炎症

获取原文
获取原文并翻译 | 示例
           

摘要

Background-: The pathophysiology of aortic stenosis is incompletely understood, and the relative contributions of valvular calcification and inflammation to disease progression are unknown. Methods and Results-: Patients with aortic sclerosis and mild, moderate, and severe stenosis were compared prospectively with age-and sex-matched control subjects. Aortic valve severity was determined by echocardiography. Calcification and inflammation in the aortic valve were assessed by 18F-sodium fluoride (18F-NaF) and 18F-fluorodeoxyglucose (18F-FDG) uptake with the use of positron emission tomography. One hundred twenty-one subjects (20 controls; 20 aortic sclerosis; 25 mild, 33 moderate, and 23 severe aortic stenosis) were administered both 18F-NaF and 18F-FDG. Quantification of tracer uptake within the valve demonstrated excellent interobserver repeatability with no fixed or proportional biases and limits of agreement of ±0.21 (18F-NaF) and ±0.13 (18F-FDG) for maximum tissue-to-background ratios. Activity of both tracers was higher in patients with aortic stenosis than in control subjects (18F-NaF: 2.87±0.82 versus 1.55±0.17; 18F-FDG: 1.58±0.21 versus 1.30±0.13; both P<0.001). 18F-NaF uptake displayed a progressive rise with valve severity (r=0.540, P<0.001), with a more modest increase observed for 18F-FDG (r=0.218, P<0.001). Among patients with aortic stenosis, 91% had increased 18F-NaF uptake (>1.97), and 35% had increased 18F-FDG uptake (>1.63). A weak correlation between the activities of these tracers was observed (r=0.174, P<0.001). Conclusions-: Positron emission tomography is a novel, feasible, and repeatable approach to the evaluation of valvular calcification and inflammation in patients with aortic stenosis. The frequency and magnitude of increased tracer activity correlate with disease severity and are strongest for 18F-NaF. Clinical Trial Registration-: http://www.clinicaltrials.gov. Unique identifier: NCT01358513.
机译:背景:主动脉瓣狭窄的病理生理学尚不完全清楚,并且瓣膜钙化和炎症对疾病进展的相对作用尚不清楚。方法和结果-:将年龄,性别匹配的对照对象进行比较,对主动脉硬化,轻度,中度和重度狭窄的患者进行前瞻性比较。主动脉瓣严重程度通过超声心动图确定。主动脉瓣钙化和炎症通过正电子发射断层扫描通过18F-氟化钠(18F-NaF)和18F-氟脱氧葡萄糖(18F-FDG)摄取进行评估。分别对18位受试者(20名对照组; 20名主动脉硬化; 25名轻度,33名中度和23名严重主动脉狭窄)进行了治疗。瓣膜内示踪剂摄取的定量显示了极好的观察者间重复性,没有固定或成比例的偏差,并且最大组织与背景之比的一致极限为±0.21(18F-NaF)和±0.13(18F-FDG)。主动脉狭窄患者的两种示踪剂的活性均高于对照组(18F-NaF:2.87±0.82对1.55±0.17; 18F-FDG:1.58±0.21对1.30±0.13;两者均P <0.001)。 18F-NaF的摄取随着瓣膜严重程度的增加而逐渐升高(r = 0.540,P <0.001),而18F-FDG的升高更为适度(r = 0.218,P <0.001)。在患有主动脉瓣狭窄的患者中,91%的18F-NaF摄取增加(> 1.97),35%的18F-FDG摄取增加(> 1.63)。观察到这些示踪剂的活性之间的相关性较弱(r = 0.174,P <0.001)。结论:正电子发射断层扫描是一种新颖,可行且可重复的方法,用于评估主动脉瓣狭窄患者的瓣膜钙化和炎症。示踪剂活动增加的频率和幅度与疾病严重程度相关,并且对于18F-NaF最强。临床试验注册-:http://www.clinicaltrials.gov。唯一标识符:NCT01358513。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号